InflaRx to present at biotech symposium

InflaRx N.V., a biopharmaceutical firm specializing in anti-inflammatory treatments, has confirmed its participation in the upcoming Raymond James 2026 Biotech Innovation Symposium. The company will present its latest advancements and strategic outlook within the rapidly evolving biotech landscape. This event offers a significant platform for InflaRx to engage with investors and industry leaders, highlighting its pipeline and potential contributions to therapeutic innovation. The symposium is expected to draw key figures from the biotechnology sector, providing valuable networking and exposure opportunities for InflaRx as it continues its development efforts.